Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1995 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
N Engl J Med. 2021 Nov 4;385(19):1774-1785. doi: 10.1056/NEJMoa2113017. Epub 2021 Sep 22.
N Engl J Med. 2021.
PMID: 34551225
Free PMC article.
Clinical Trial.
More than 96% of participants received both injections, 2.3% had evidence of SARS-CoV-2 infection at baseline, and the median follow-up was 5.3 months in the blinded phase. Vaccine efficacy in preventing Covid-19 illness was 93.2% (95% confidence interval [CI], 91.0 to 94. …
More than 96% of participants received both injections, 2.3% had evidence of SARS-CoV-2 infection at baseline, and the median follow- …
Localization of [125I]IGF-I binding on the ovine pars tuberalis.
Williams LM, Kelly D, Hannah LT, Morgan PJ.
Williams LM, et al. Among authors: hannah lt.
J Neuroendocrinol. 1995 Dec;7(12):931-8. doi: 10.1111/j.1365-2826.1995.tb00738.x.
J Neuroendocrinol. 1995.
PMID: 8745271
In contrast in the rat [125I]IGF-I binding was restricted to the median eminence region of the brain and was not detectable over the pars tuberalis....
In contrast in the rat [125I]IGF-I binding was restricted to the median eminence region of the brain and was not detectable over the …
Item in Clipboard
Cite
Cite